Medtronic

Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

Retrieved on: 
Monday, January 8, 2024
Health, Medical Devices, Health Technology, Fitness & Nutrition, Managed Care, General Health, Biotechnology, Marketing, Partnership, FDA, Growth, Obesity, Medtronic, Investment, Patient

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023.

Key Points: 
  • Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023.
  • The Company also issued its preliminary 2024 outlook, reflecting an increased focus on driving sustained procedural volume growth ahead of key FDA milestones while reducing cost structure, optimizing capital structure, and accelerating the path to profitability.
  • “We believe procedure volume growth of 30% in 2023 substantiates the significant underlying demand for the Allurion Program, particularly as the efficacy of our offerings continues to be validated by patient results,” said Dr. Shantanu Gaur, CEO of Allurion.
  • I am enthusiastic about our growth catalysts in 2024 and beyond, as we continue to enhance outcomes for patients and create value for our shareholders."

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

Retrieved on: 
Monday, January 8, 2024
Medical Devices, Health, Hospitals, Surgery, General Health, Biotechnology, Spine, Medtronic, Multimedia, CFO, Information technology, Extremities, Treasury, Interim, Financial system, Senior, Management

(NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors.

Key Points: 
  • (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors.
  • In conjunction with Mr. Calafiore stepping into his role as CEO, the Company has announced the appointment of Julie Andrews as Chief Financial Officer.
  • Ms. Andrews previously served as CFO for Smart Wires Technology, where she led all finance, tax, treasury, accounting, information technology, and investor relations functions.
  • “Our search for these critical management roles was executed quickly and thoroughly, with many highly qualified candidates expressing interest in leading Orthofix.

Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor

Retrieved on: 
Monday, January 8, 2024
Medtronic, Meal, CGM, IOS, FDA, Insulin, Diabetes, CE marking, Hyperglycemia, CE, Outline of health sciences, Android, Snack, EVP, Medical device

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable, all-in-one continuous glucose monitor (CGM) requiring no fingersticks or overtape. Simplera Sync™ features an improved user experience with a simple, two-step insertion process and is half the size of previous Medtronic sensors.*  

Key Points: 
  • Simplera Sync™ features an improved user experience with a simple, two-step insertion process and is half the size of previous Medtronic sensors.
  • *
    The MiniMed 780G system with Simplera Sync™ sensor will be available in Europe via limited release in spring 2024.
  • Today, the MiniMed™ 780G system can be used with the Guardian™ 4 sensor.
  • With this "treat to target" approach, the system more closely mirrors the glucose levels of someone not living with diabetes.

Dr. Stephen Oesterle and Dr. Joshua Makower Join Patient Square Capital as Senior Advisors

Retrieved on: 
Thursday, January 4, 2024
Paragon, Acclarent, Mechanical engineering, Health, Yale School of Medicine, Stanford University, Patent, Biological engineering, SVP, Teleflex, Bard (company), Baxter International, MIT, American Institute, MBA, Columbia University, CeramTec, National academy, Mechanical, Yale school, Flexner Report, Friends, Therapy, Invention, Biomedicine, Patient, Harvard Medical School, Hospital, MD, Medtronic, Investment, Harvard College, Interventional cardiology, Nursing

MENLO PARK, Calif., Jan. 4, 2024 /PRNewswire/ -- Patient Square Capital , a leading health care investment firm, today announced that Dr. Joshua Makower and Dr. Stephen Oesterle joined as Senior Advisors to the firm.

Key Points: 
  • MENLO PARK, Calif., Jan. 4, 2024 /PRNewswire/ -- Patient Square Capital , a leading health care investment firm, today announced that Dr. Joshua Makower and Dr. Stephen Oesterle joined as Senior Advisors to the firm.
  • Dr. Makower will also be joining the board of Elevage Medical Technologies, a Patient Square portfolio company focused on growth-stage medical technologies.
  • "Dr. Oesterle and Dr. Makower are undisputed leaders, innovators, and investors in the medical technology space," said Neel Varshney, M.D., Founding Partner of Patient Square.
  • "The resources Patient Square has assembled for the ultimate goal of improving patient outcomes are transformational," added Dr. Oesterle.

Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner

Retrieved on: 
Thursday, January 4, 2024
Other Manufacturing, Surgery, Medical Devices, Engineering, Health Technology, Manufacturing, Biotechnology, Other Health, Health, Acclarent, Biomedical technology, Stanford University, Partner, Student, J&J, Mechanical engineering, MIT, American Institute, MBA, MD, Education, Columbia University, Invention, National academy, Patent, Biomedicine, Prostate, Biological engineering, Medtronic, Investment, Patient, Mechanical, Curriculum, Sofinnova, Medical device

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign , has joined Sofinnova as an advisory Venture Partner.

Key Points: 
  • Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign , has joined Sofinnova as an advisory Venture Partner.
  • He is the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.
  • Dr. Makower was a longtime partner in NEA’s healthcare practice, advising the healthcare team and medtech/healthtech investing practice.
  • Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, said: “We are incredibly fortunate to have Josh on board.

Vensana Capital Strengthens Team with Promotions and Addition of Venture Partner

Retrieved on: 
Thursday, January 4, 2024
Other Professional Services, Finance, Health, Consulting, Health Technology, Professional Services, Technology, Other Technology, Yee, Navigant Consulting, Associate, Piper Sandler Companies, Coronary thrombosis, ATS Medical, Thoratec, Cardiology, EV3, Biotechnology, CFO, Partner, Acquisition, Boston Scientific, Medtech, NEA, Amrinder Singh, Therapy, MGM+, Medtronic, Engineering, Elective surgery, Investment, IPO, KPMG, Patient, CRG, Capital, Neurology, DSM-IV codes, Management

Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.

Key Points: 
  • Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.
  • The firm also announced the addition of veteran medtech leader Bill Hoffman as a Venture Partner.
  • “Since launching Vensana in 2019, we have set out to build the deepest, most experienced team in our sector.
  • Bill Hoffman joins Vensana Capital as a Venture Partner.

FluidForm Bio™ Welcomes New Executive Leadership

Retrieved on: 
Wednesday, January 3, 2024
MSF, Marketing, Marketing communications, Suffolk University, Senior, Quality of life, Integration, GRC, Business administration, JD, Colby College, College, Marist College, Medtronic, General counsel, Social media, Growth, IPO, Dell, Dell EMC, Saint Michael's College, Management

WALTHAM, Mass., Jan. 3, 2024 /PRNewswire/ -- FluidForm Bio™ announced that it has named Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.

Key Points: 
  • Paris is a seasoned legal executive and commercial attorney who has counseled domestic and multinational publicly traded and privately held organizations.
  • Previously, Paris held numerous leadership positions at Insulet Corporation, Medtronic, and Covidien.
  • Prior to joining FluidForm Bio™, she served as Senior Vice President of Marketing of SAI360, orchestrating a corporate rebrand and spearheading the marketing strategy.
  • Prior to joining FluidForm Bio™, Lenz served as a principal analyst at Dell EMC leading company-wide technology projects.

Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

Retrieved on: 
Wednesday, January 3, 2024
Technology, Research, Medical Devices, Genetics, Nanotechnology, Biotechnology, Health, Data Management, Science, Policy, Case Western Reserve University, Biomedical engineering, Medtech, Boy, Boy Scouts, Engineering, Education, University, Innovation, Internet, Biomedicine, Artificial intelligence, Medtronic, Pulse, Doctor of Philosophy, Entrepreneurship, Publication, Patient, Organization, Robotics

IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS) , today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse.

Key Points: 
  • IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS) , today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse.
  • Mr. Hess is currently an adjunct professor in the Department of Biomedical Engineering at the University of Minnesota.
  • I believe that IEEE Pulse is indeed the ideal publication to fulfill this mission,” commented Metin Akay, Ph.D., IEEE EMBS Ambassador.
  • IEEE Pulse is the flagship magazine for IEEE EMBS, which reports on a broad variety of topics related to biomedical engineering.

South Africa Medical and Surgical Equipment Supply and Manufacturing Industry Report 2023 Featuring Medtronic, Johnson & Johnson, Siemens, Southern Medical, CapeRay and Ascendis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 2, 2024
Surgery, Health, Medical Supplies, Google Images, Trauma, Medicine, Prevalence, Medical device, Private sector, Supply, Medtronic, Instrument, Unemployment, Public sector, Patient

The "The Supply and Manufacture of Medical and Surgical Equipment Industry in South Africa 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Supply and Manufacture of Medical and Surgical Equipment Industry in South Africa 2023" report has been added to ResearchAndMarkets.com's offering.
  • South Africa's medical devices industry consists of mostly small to medium enterprises and larger multinational companies with local subsidiaries or partners.
  • The latter dominate the industry as imports account for as much as 90% of the market.
  • There are profiles of 65 companies including international companies present in South Africa such as Medtronic, Johnson & Johnson Medical, Siemens, notable pharmaceutical wholesalers and retailers, and other notable players such Southern Medical, CapeRay and Ascendis.

Bioventus Names Robert Claypoole as President and Chief Executive Officer

Retrieved on: 
Tuesday, December 19, 2023
Covidien, History, Johnson & Johnson, Medtronic, Growth, Patient, Management

DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’ President and Chief Executive Officer and a member of its Board of Directors, effective January 10, 2024.

Key Points: 
  • DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’ President and Chief Executive Officer and a member of its Board of Directors, effective January 10, 2024.
  • Mr. Claypoole succeeds Mr. Anthony Bihl who has served as interim CEO and a director on the Board since April 2023.
  • He most recently served as Executive Vice President at Mölnlycke Health Care AB, where he led Mölnlycke’s $1.2 billion global Wound Care business.
  • “We are excited to have Rob join Bioventus and build upon the significant improvements made this year to further elevate our execution and overall performance,” said William A. Hawkins, Bioventus’ executive chairman.